Stock Marketplace/Tier Changes 10/15/2019
10/15/2019
Stock Marketplace/Tier Changes 10/15/2019
10/15/2019 VIVC Vivic Corp. Pink Current OTCQB Common Stock
10/15/2019 USRM U.S. Stem Cell, Inc. OTCQB Pink Current Common Stock
10/15/2019 TNGL Tonogold Resources, Inc. Pink No Information Pink Limited Common Stock
10/15/2019 NBGV NewBridge Global Ventures, Inc. OTCQB Pink No Information Common Stock
10/15/2019 GDLCF Grayscale Digital Large Cap Fund LLC Pink Current Pink No Information Ordinary Shares
10/15/2019 FPWM 1st Prestige Wealth Management Pink No Information Pink Limited Common Stock
10/15/2019 EXMT Anything Technologies Media Inc. Pink No Information Pink Limited Common Stock
10/15/2019 DPSM 3D Pioneer Systems Inc. Pink Limited Pink Current Common Stock
10/15/2019 DINO Dino Energy Corp Pink Limited Pink Current Common Stock
10/15/2019 AVCNF Avicanna Inc. Pink Current OTCQX International Ordinary Shares
10/15/2019 AIVN American International Ventures, Inc. Pink Limited Pink Current Common Stock
10/14/2019 XSPT XSport Global, Inc. OTCQB Pink Current Common Stock
10/14/2019 GDLCF Grayscale Digital Large Cap Fund LLC Grey Market Pink Current Ordinary Shares
10/14/2019 GDET GD Entertainment & Technology, Inc. Pink Limited Pink Current Common Stock
10/11/2019 WODI WOD Retail Solutions Inc. Pink No Information Pink Current Common Stock
10/11/2019 SEII Sharing Economy International Inc. Pink No Information Pink Current Common Stock
10/11/2019 KITL Kisses from Italy Inc. Pink Current OTCQB Common Stock
10/11/2019 ITKH iTeknik Holding Corporation Pink Limited Pink Current Common Stock
10/11/2019 GWPD GP Solutions, Inc. Pink Current Grey Market Common Stock
10/10/2019 USBL United States Basketball League Inc. Pink No Information Pink Current Common Stock
10/10/2019 USATP USA Technologies, Inc. Pink No Information Pink Current Preferred Stock
10/10/2019 USAT USA Technologies, Inc. Pink No Information Pink Current Common Stock
10/10/2019 POLXF Polydex Pharmaceuticals Ltd. Pink Limited Pink Current Ordinary Shares
10/10/2019 NVLNF Novelion Therapeutics Inc. Pink Limited Pink No Information Common Stock
10/10/2019 LVCA Lake Victoria Mining Company, Inc. Pink Limited Pink Current Common Stock
Scroll down for more posts ▼
Top 10 Most Recent News Articles
High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...
Continue Reading
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...
Continue Reading
A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...
Continue Reading
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....
Continue Reading
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Top 5 Most Recently Viewed Articles
Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...
Continue Reading
Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...
Continue Reading
Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...
Continue Reading
Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...
Continue Reading
B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...
Continue Reading